Načítá se...
Doxorubicin conjugated quantum dots to target alveolar macrophages/inflammation
The ability to provide targeted therapeutic delivery in the lung would be a major advancement in pharmacological treatments for many pulmonary diseases. Critical issues for such successful delivery would require the ability to target specific cell types, minimize toxicity (i.e. inflammatory response...
Uloženo v:
| Hlavní autoři: | , , , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2010
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3363005/ https://ncbi.nlm.nih.gov/pubmed/20887813 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.nano.2010.09.001 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|